A Super Bowl ad for telehealth company Hims & Hers has sparked concern among Senators Durbin and Marshall due to insufficient disclosure of risks and lack of FDA approval disclaimers. The senators argue the ad violates advertising norms for pharmaceuticals by omitting side effect disclosures, prompting a letter to the FDA for regulatory review. Hims & Hers defended their advertisement as compliant with laws, while the scrutiny reflects ongoing debates surrounding health advertising and regulatory practices, which may intensify post-broadcast.
The bipartisan concerns regarding a Super Bowl ad for telehealth company Hims & Hers highlight tensions between consumer safety and advertising freedom in healthcare.
Senators Durbin and Marshall have raised alarms over the lack of necessary disclosures and safety information typically mandated in pharmaceutical advertisements.
Collection
[
|
...
]